Geoffrey L. Liu

Oncology

Charlestown, MA 02129

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 521 publications

Investigating the repurposing potential of immune checkpoint inhibition for cancer treatment using Mendelian randomisation.

Investigating the repurposing potential of immune checkpoint inhibition for cancer treatment using Mendelian randomisation.

Journal: Research square

Published: August 20, 2026

Author Correction: Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma.

Author Correction: Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma.

Journal: Nature

Published: August 11, 2026

First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.

First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.

Journal: The New England journal of medicine

Published: May 29, 2026

First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.

First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.

Journal: The New England journal of medicine

Published: May 29, 2026

Comparative efficacy of taletrectinib versus first-generation TKIs in TKI-naïve ROS1+ non-small cell lung cancer: A matching-adjusted indirect comparison.

Comparative efficacy of taletrectinib versus first-generation TKIs in TKI-naïve ROS1+ non-small cell lung cancer: A matching-adjusted indirect comparison.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 15, 2026

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Journal: Frontiers in oncology

Published: May 09, 2026

Consensus recommendations on surveillance and survivorship for patients with unresectable/stage IV non-small cell lung cancer after completing Immunotherapy: a Delphi study by Canadian experts.

Consensus recommendations on surveillance and survivorship for patients with unresectable/stage IV non-small cell lung cancer after completing Immunotherapy: a Delphi study by Canadian experts.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 07, 2026

Long-term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy.

Long-term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy.

Journal: Cancer

Published: April 08, 2026

Exploring the Utility of Cell-Free DNA Hydroxymethylation Profiling in Small-Cell Lung Cancer.

Exploring the Utility of Cell-Free DNA Hydroxymethylation Profiling in Small-Cell Lung Cancer.

Journal: International journal of molecular sciences

Published: March 25, 2026

Clinical Factors and Income Status are Associated with Depression and Anxiety in Head and Neck Cancer Patients.

Clinical Factors and Income Status are Associated with Depression and Anxiety in Head and Neck Cancer Patients.

Journal: Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale

Published: March 19, 2026

Prophylactic Cranial Irradiation and Survival in Limited-Stage SCLC: A Multicenter Real-World Analysis From the Canadian SCLC Database (CASCADE).

Prophylactic Cranial Irradiation and Survival in Limited-Stage SCLC: A Multicenter Real-World Analysis From the Canadian SCLC Database (CASCADE).

Journal: JTO clinical and research reports

Published: March 11, 2026

Somatic alterations in TP53, PIK3CA, and CCND1 reveal exposure-driven patterns in oral and oropharyngeal tumors.

Somatic alterations in TP53, PIK3CA, and CCND1 reveal exposure-driven patterns in oral and oropharyngeal tumors.

Journal: Journal of the National Cancer Institute

Published: February 07, 2026

Showing 1-12 of 521

Last Updated: 09/26/2026